NCT06610955 Comparison of Two Different Intensity Exercises on Young Women With Obesity
| NCT ID | NCT06610955 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ahi Evran University Education and Research Hospital |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-18 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-10-18 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obesity is one of the most common preventable public health problems. Diet regulation and exercise practices are the most commonly used methods in reducing fat tissue. There are various exercise methods applied in the weight loss process and the effects of different types of exercise modalities on body fat rate and metabolic status.The aim of our study is to determine the effects of high intensity interval exercise and moderate intensity continuous exercise on serum , omentin, leptin and adiponectin levels, anthropometric measurements used in obesity follow up, body fat percentage and their effects on the quality of sleep and life of women with obesity.
Eligibility Criteria
Inclusion Criteria: * Female between the age of 18-45 * BMI 30-40 kg/m² * Primary obesity Exclusion Criteria: * Patients with cardiac, pulmonary, endocrinological, rheumatological diseases * Pregnancy and breastfeeding * Using antipsychotics, antidepressants (lithium, tricyclic antidepressants, mono amino oxidase inhibitors), anticonvulsants, antihistamines, glucocorticoids, antidiabetics (sulfonylureas, insulins, glitazones) sex hormones * Using oral contraceptives * History of bariatric surgery * Patients using obesity medication in the last 6 months, complying with a regular diet and exercise program * Presence of orthopedic or neurological problems that difficulty of participate aerobic exercise training
Contact & Investigator
Figen Tuncay, Professor
PRINCIPAL INVESTIGATOR
Ahi Evran Univeristy
Frequently Asked Questions
Who can join the NCT06610955 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06610955 currently recruiting?
Yes, NCT06610955 is actively recruiting participants. Contact the research team at figentuncay3206@hotmail.com for enrollment information.
Where is the NCT06610955 trial being conducted?
This trial is being conducted at Kırşehir, Turkey (Türkiye).
Who is sponsoring the NCT06610955 clinical trial?
NCT06610955 is sponsored by Ahi Evran University Education and Research Hospital. The principal investigator is Figen Tuncay, Professor at Ahi Evran Univeristy. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.